Type 2 diabetes linked to colorectal cancer risk in men

December 6, 2018

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the British Journal of Cancer.

Yanan Ma, from China Medical University in Shenyang, and colleagues followed 87,523 women from the Nurses' Health Study and 47,240 men from the Health Professionals Follow-up Study to examine the correlation of T2D and its duration with the for incident CRC.

The researchers documented 3,000 cases of CRC during a follow-up of 32 years. Among men, the risk for CRC was increased for those with versus those without T2D (hazard ratio, 1.42; 95 percent confidence interval, 1.12 to 1.81). The positive association remained in sensitivity analyses excluding CRC identified within one year of diabetes diagnosis and excluding patients with T2D using hypoglycemic medications. Among , there was a positive but not statistically significant association between T2D and CRC risk (hazard ratio, 1.17; 95 percent confidence interval, 0.98 to 1.39).

"More studies are warranted to further investigate the underlying mechanisms," the authors write. "Our finding further underscores the importance of enhancing the effort to reduce the emerging epidemics of type 2 diabetes for prevention and control."

Explore further: Consuming caffeine from coffee reduces incident rosacea

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

Type 2 diabetes ups risk of renal cancer in women, but not men

May 8, 2018
(HealthDay)—Type 2 diabetes is independently associated with a greater risk of renal cell carcinoma (RCC) in women, but not in men, according to a study published online April 20 in Diabetes Care.

Risk of venous thromboembolism recurrence high

October 1, 2018
(HealthDay)—The risk of recurrence after incident venous thromboembolism is high, particularly among patients with cancer-related venous thromboembolism, according to a study published in the September issue of The American ...

Never breastfeeding linked to increased risk of T1DM

May 12, 2017
(HealthDay)—Never breastfeeding seems to be associated with increased risk of type 1 diabetes, according to a study published online May 9 in Diabetes Care.

Cancer development linked to increased diabetes risk

June 11, 2018
(HealthDay)—Cancer development is associated with increased risk of subsequent type 2 diabetes mellitus, according to a study published online June 7 in JAMA Oncology.

PPI-gastric cancer link remains after H. pylori eradication

November 2, 2017
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Researchers study abnormal blood glucose levels of discharged patients

December 14, 2018
University of Minnesota Medical School researchers decided to delve into an area where little data currently exists. They wanted to know what happens after these patients with abnormal blood glucose measurements are discharged? ...

Researchers zero in on potential therapeutic target for diabetes, associated diseases

December 14, 2018
A recent study led by researchers in Texas A&M University's department of nutrition and food science shows how a novel regulatory mechanism serves as an important biomarker for the development of diabetes, as well as a potential ...

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.